METHYL 2-(6-BROMO-1H-INDOL-3-YL)-2-OXOACETATE, 95.0%, 100mg

2-(6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-benzo[d]imidazol-1-yl)ethan-1-ol, 98%, 250mg

3-Bromo-6-oxo-1,6-dihydropyridine-2-carbonitrile, 95.0%, 5g

2-(3-Methylpiperidin-1-yl)aniline, 98%, 100mg

Pentane [Standard Material for GC]>99.5%(GC)5mL

4-Bromo-5-methyl-1H-pyrazol-3-ylamine, 95.0%, 100g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)propanoic acid, 97%, 1g

3-(6-OXO-1,6-DIHYDRO-PYRIDAZIN-3-YL)-BENZONITRILE, 97.0%, 100g

4-(1-Pyrrolidinyl)piperidine, 98.0%, 1g

2-Bromo-1,3-diethylbenzene, 95.0%, 1g

Silane, [[(2E)-3-methoxy-1-methylene-2-propenyl]oxy]trimethyl-, 94%, 5g

3-BROMO-2-IODOQUINOLINE, 95.0%, 10g

(4-{[(tert-butoxy)carbonyl]amino}butyl)(diazyn-1-ium-1-yl)azanide, 98%, 10g